Argenx Se (ARGX) EBT Growth (1y) (2017 - 2026)
Argenx Se (ARGX) EBT Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.10% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,140.26% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 71.54% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.15% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 88.57% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | 9,460.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 88.57% |
| Mar 31, 2026 | 116.44% |
| Dec 31, 2025 | 380.97% |
| Sep 30, 2025 | 338.58% |
| Jun 30, 2025 | 2,012.28% |
| Mar 31, 2025 | 372.17% |
| Dec 31, 2024 | 237.06% |
| Sep 30, 2024 | 205.70% |
| Jun 30, 2024 | -117.89% |
| Mar 31, 2024 | -197.60% |
| Dec 31, 2023 | -248.35% |
| Sep 30, 2023 | -134.55% |
| Jun 30, 2023 | 112.38% |
| Mar 31, 2023 | -66.89% |
| Dec 31, 2022 | -83.16% |
| Sep 30, 2022 | 204.40% |
| Jun 30, 2022 | -743.33% |
| Mar 31, 2022 | 886.60% |
| Dec 31, 2021 | 229.98% |
| Sep 30, 2021 | -29.05% |